F&S Reports · Published 2026-02-21 · DOI 10.1016/j.xfre.2026.02.007
Objective: To study whether incident endometriosis diagnosis, staging, and typology are associated with concurrent elevated serum inflammatory markers interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor alpha (TNF-α). Design: Cross-sectional analysis using data from the Endometriosis, Natural History, Diagnosis, and Outcomes (ENDO) study. Subjects: A total of 395 premenopausal females in Utah, with no prior endometriosis diagnosis, participating in diagnostic or therapeutic gynecologic laparoscopy/laparotomy, 2007–2009. Exposure: Endometriosis diagnosis, staging (minimal, mild, moderate, severe), and typology (superficial endometriosis [SE], deep infiltrating endometriosis [DE], ovarian endometrioma [OE]), determined through postoperative reports and the revised American Society for Reproductive Medicine classification. Main Outcome Measure: Elevated serum cytokine concentrations defined as IL-6 ≥2 pg/mL, IL-8 ≥3 pg/mL, and TNF-α ≥7.5 pg/mL. Adjusted prevalence ratios (aPR) and 95% confidence intervals (CI) were estimated using generalized linear models controlling for age, body mass index (BMI), race/ethnicity, serum cotinine, and reported use of oral hormonal contraception within the past 2 years. Results: Participants were on average 33 years at time of gynecologic laparoscopy/laparotomy, non-Hispanic white (79%), married (75%), with a BMI of 18.5–24.9 kg/m2 (39%), nonsmokers (83% serum cotinine <5 ng/mL), and reported use of oral hormonal contraception within the past 2 years (23%). Forty-two percent (n = 166) were diagnosed with incident endometriosis. Ten percent had elevated IL-6, 7% had elevated IL-8, and 13% had elevated TNF-α, with 26% having an elevation of at least one marker. We found no differences between those with, vs. without, endometriosis and prevalence of elevated serum IL-6 (10% vs. 10%; aPR: 1.17; 95% CI: 0.59, 2.30), IL-8 (5% vs. 8%; aPR: 0.60; 95% CI: 0.20, 1.84), or TNF-α (16% vs. 12%; aPR: 1.30; 95% CI: 0.68, 2.51). There was also no indication that endometriosis was associated with continuous measures of IL-6, IL-8, or TNF-α or that staging or typology was associated with any of the inflammatory biomarkers. Conclusion: This study found no associations between incident endometriosis diagnosis, staging, typology, and concurrent serum inflammatory markers IL-6, IL-8, and TNF-α. Our results are in line with several other studies finding null associations between systemic cytokines, measured via blood-derived specimens, and endometriosis. Whether other cardiovascular disease risk biomarkers, including lipoprotein abnormalities, are associated with endometriosis warrants further research.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →